Loading…
Academic Journal
A polysaccharide from Dendrobium devonianum induces antitumour immune responses by promoting TLR4-mediated M1 macrophage polarisation
Shan-Yao Pu, Yue-Guo Wu, Can Ke, Wen Tang, Li-Fei Zhou, Feng-Yang Chen
Food and Agricultural Immunology, Vol 36, Iss 1 (2025)
Saved in:
| Title | A polysaccharide from Dendrobium devonianum induces antitumour immune responses by promoting TLR4-mediated M1 macrophage polarisation |
|---|---|
| Authors | Shan-Yao Pu, Yue-Guo Wu, Can Ke, Wen Tang, Li-Fei Zhou, Feng-Yang Chen |
| Publication Year |
2025
|
| Source |
Food and Agricultural Immunology, Vol 36, Iss 1 (2025)
|
| Description |
Background: DvP-1 is a polysaccharide from D. devonianum which serves as a TLR4 agonist. The present study evaluated the antitumour effects of DvP-1 and investigated the underlying mechanisms.Materials and Methods: CT26 colon carcinoma-bearing mice were intratumorally injected with DvP-1 and tumour size was monitored. The proportion and activity of several kinds of immune cells in the tumour immune microenvironment (TIME) were further examined using a flow cytometer. RAW 264.7 cells were induced to M1 and M2 macrophage polarisation which were used to investigate the effects of DvP-1. TLR4 antagonist as well as several other TLR antagonists were used to validate if DvP-1 act through TLR4.Results: DvP-1 significantly reduced the growth of CT26 colon carcinoma in mice and enhanced antitumour immune responses in the TIME by decreasing the proportion of immunosuppressive Foxp3 + CD4+ Treg cells and increasing the proportion of effector CD4+ T cells, CD8+ T cells, and CD11b+ F4/80+ macrophages. In addition, DvP-1 significantly increased the expression of CD80 and decreased the expression of CD206 on macrophages. Further mechanism study indicated that DvP-1 mainly promoted M1 macrophage polarisation by TLR4.Conclusion: DvP-1 is a promising candidate for enhancing the efficacy of cancer immunotherapy and warrants further development.
|
| Document Type |
article
|
| Language |
English
|
| Publisher Information |
Taylor & Francis Group, 2025.
|
| Subject Terms | |
